4203 articles
A Christchurch-based ophthalmologist’s collection of popular articles for general practitioners (GPs) on how to diagnose and treat common eye problems has been revised and is now freely available online at gpeyes.co.nz
In a breakthrough for diagnosing cerebral visual impairment (CVI), Dr Nicola McDowell, a senior lecturer at Massey University, has developed a specialised tool, the Austin Assessment app.
Scientists at Nanyang Technological University Singapore (NTU Singapore) have developed rice-grain-sized soft robots that can transport up to four different drugs and release them in reprogrammable orders and doses.
A recent review found no irreversible visual function loss or ocular structural damage in individuals undergoing repeated low-level red-light (RLRL) therapy for myopia. Analysing 20 studies (i
A small US trial of a sustained-release intravitreous implant found geographic atrophy (GA) lesion growth was two-thirds less in treated eyes compared to controls over three months. Inflammasom
US researchers found patients with thyroid eye disease receiving teprotumumab (Tepezza) were 24 times more likely to suffer hearing-related impairments. Writing in Ophthalmic Plastic and Reconstruct
Tauranga-based optometrist Karl Fischer has been struck off the register by the Health and Disability Tribunal and ordered to pay costs and a fine totalling $25,500.
Designed with both form and function in mind, ProDesign’s masculine Alucorner frame is crafted from aluminium, offering durability and a lightweight feel. The built-in flex provides enhanced comfort for all-day wear, while the easily mountable lenses add practicality to the design.
Extremely thin and lightweight, Serengeti’s sun style Positano brings a modified square shape, offering a slightly retro look. Perfect for long summer drives, they are available with Serengeti’s mineral polarised driver’s lens (category 2–3, overcast to medium light conditions), which also suits eve
The inaugural Nelson event celebrating all things running, The Spectacle, was hailed a resounding success with 1,500 competitors and crowds lining the streets on a scorching hot summer’s day in December.
EssilorLuxottica has signed an agreement to acquire Espansione Group, the Italian manufacturer of Meibomask, a low-level light therapy (LLLT) device, and OPE (optimal power energy) intense pulsed ligh
The authors of a study of low-dose atropine to treat myopia in European children said the results favour 0.05% over 0.01% nightly eye-drop use, despite more adverse events in the former group.
